Our team includes specialists from Immunology and Cellular Therapy who have expertise in assessing and treating the long-term effects of primary immune deficiencies and related conditions.
May 26, 2023
CHOP researchers have shown that IgA acts as a “tuner” that regulates the number of microbes the body sees every day, restraining a systemic immune response.
Nov 15, 2021
Using a model developed at CHOP, researchers find high cost of treatment most likely to prevent premature death in patients with agammaglobulinemia undermines its benefits.